Clinical and neuropathological analysis of Down syndrome over 7 decades of life.
作者信息
Sukreet Sonal, Goodwill Vanessa S, Ngolab Jennifer, Kim Ha Y, Leisher Solana, Salehi Sahar, Rafii Michael S, Hiniker Annie, Rissman Robert A
机构信息
Department of Physiology and Neurosciences, Keck School of Medicine of the University of Southern California, San Diego, CA, United States.
Department of Pathology, UC San Diego School of Medicine, La Jolla, CA, United States.
出版信息
J Neuropathol Exp Neurol. 2025 Feb 1;84(2):168-173. doi: 10.1093/jnen/nlae110.
Abstract
摘要
相似文献
1
Clinical and neuropathological analysis of Down syndrome over 7 decades of life.唐氏综合征70多年生命历程的临床与神经病理学分析。
J Neuropathol Exp Neurol. 2025 Feb 1;84(2):168-173. doi: 10.1093/jnen/nlae110.
2
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis.后部皮质萎缩的人口统计学、临床、生物标志物和神经病理学相关性：一项国际队列研究和个体参与者数据荟萃分析。
Lancet Neurol. 2024 Feb;23(2):168-177. doi: 10.1016/S1474-4422(23)00414-3.
3
Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.基于人群的痴呆神经病理学研究：设计、方法与调查领域——一项系统综述
BMC Neurol. 2006 Jan 9;6:2. doi: 10.1186/1471-2377-6-2.
4
Study of neuropathological changes and dementia in 100 centenarians in The 90+ Study.《90+ 研究中 100 名百岁老人的神经病理学变化与痴呆研究》
Alzheimers Dement. 2023 Aug;19(8):3417-3425. doi: 10.1002/alz.12981. Epub 2023 Feb 16.
5
Neuropathological comorbidity, genetics and cognition in a Chinese community-based autopsy cohort.中国社区尸检队列中的神经病理学合并症、遗传学与认知
Brain. 2025 Feb 4. doi: 10.1093/brain/awaf039.
6
Walking capacity and its association with quality of life among children with down syndrome in Saudi Arabia.沙特阿拉伯唐氏综合征儿童的步行能力及其与生活质量的关系。
BMC Pediatr. 2024 Jan 19;24(1):55. doi: 10.1186/s12887-023-04519-8.
7
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.唐氏综合征、21号染色体部分三体与阿尔茨海默病的缺失：淀粉样前体蛋白（APP）的作用
J Alzheimers Dis. 2017;56(2):459-470. doi: 10.3233/JAD-160836.
8
Diagnosis for Neonatal Sepsis-Associated Encephalopathy: Don't Forget Neuropathological Biomarkers.新生儿脓毒症相关性脑病的诊断：勿忘神经病理学生物标志物。
World Neurosurg. 2025 Apr;196:123840. doi: 10.1016/j.wneu.2025.123840. Epub 2025 Feb 26.
9
Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease.唐氏综合征相关阿尔茨海默病中的α-突触核蛋白共病病理
Alzheimers Dement. 2025 Jun;21(6):e70342. doi: 10.1002/alz.70342.
10
Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer's-type dementia.基于假说的已知 AD 风险变异研究揭示了阿尔茨海默病型痴呆中观察到的神经病理损伤的遗传基础。
Acta Neuropathol. 2024 Oct 18;148(1):55. doi: 10.1007/s00401-024-02815-w.
引用本文的文献
1
Characterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome.唐氏综合征成年和儿科患者神经退行性病变的特征分析
J Alzheimers Dis. 2025 Aug 10;107(2):13872877251362762. doi: 10.1177/13872877251362762.
本文引用的文献
1
From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.从理解到行动：探索唐氏综合征与阿尔茨海默病的分子联系以制定靶向治疗方法。
Alzheimers Dement (Amst). 2024 Apr 14;16(2):e12580. doi: 10.1002/dad2.12580. eCollection 2024 Apr-Jun.
2
Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.唐氏综合征患者中与年龄相关的阿尔茨海默病神经退行性变和神经元丢失的发育缺陷和动态分期。
Acta Neuropathol Commun. 2022 Jan 4;10(1):2. doi: 10.1186/s40478-021-01300-9.
3
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial.临床试验中检测视网膜淀粉样蛋白的可行性研究：无症状阿尔茨海默病的抗淀粉样蛋白治疗（A4）试验。
Alzheimers Dement (Amst). 2021 Aug 17;13(1):e12199. doi: 10.1002/dad2.12199. eCollection 2021.
4
Retinal Amyloid Imaging for Screening Alzheimer's Disease.用于筛查阿尔茨海默病的视网膜淀粉样蛋白成像
J Alzheimers Dis. 2021;83(2):927-934. doi: 10.3233/JAD-210327.
5
Prevalence of Common Disease Conditions in a Large Cohort of Individuals With Down Syndrome in the United States.美国一大群唐氏综合征患者中常见疾病状况的患病率。
J Patient Cent Res Rev. 2021 Apr 19;8(2):86-97. doi: 10.17294/2330-0698.1824. eCollection 2021 Spring.
6
Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye.阿尔茨海默病眼中视网膜神经节细胞层的β淀粉样蛋白免疫反应性
Front Neurosci. 2020 Jul 31;14:758. doi: 10.3389/fnins.2020.00758. eCollection 2020.
7
Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials.唐氏综合征相关阿尔茨海默病：药物预防试验的设计和实施进展。
CNS Drugs. 2020 Aug;34(8):785-794. doi: 10.1007/s40263-020-00740-6.
8
FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin Hubs.FOXO3通往长寿之路：单核苷酸多态性和染色质枢纽的启示
Comput Struct Biotechnol J. 2019 Jun 13;17:737-745. doi: 10.1016/j.csbj.2019.06.011. eCollection 2019.
9
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.边缘系统为主的年龄相关性 TDP-43 脑病（LATE）：共识工作组报告。
Brain. 2019 Jun 1;142(6):1503-1527. doi: 10.1093/brain/awz099.
10
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.阿尔茨海默病死后视网膜中的淀粉样β和磷酸化tau。
Acta Neuropathol Commun. 2018 Dec 28;6(1):147. doi: 10.1186/s40478-018-0650-x.
Zotero 插件